ClinicalTrials.Veeva

Menu

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia (DiabCare Asia)

Novo Nordisk logo

Novo Nordisk

Status

Completed

Conditions

Diabetes
Diabetes Mellitus, Type 2

Treatments

Other: No treatment given

Study type

Observational

Funder types

Industry

Identifiers

NCT01934686
U1111-1138-9049 (Other Identifier)
INS-4070

Details and patient eligibility

About

This study is conducted in Asia. The aim of this non-interventional study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Indonesia.

Enrollment

1,862 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People with type 2 diabetes mellitus (DM) who are being treated, with any of the non-pharmacological or pharmacological options, at a particular centre for at least 1 year and who have visited the centre within the last 3-6 months
  • Patients willing to sign informed consent form

Exclusion criteria

  • Previous participation in this study
  • Unable to comply with protocol requirements
  • Confirmed or suspected pregnancy

Trial design

1,862 participants in 1 patient group

Subjects with diabetes mellitus (type 2)
Treatment:
Other: No treatment given

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems